Trial intelligence / Profile preview

Misoprostol for Asymptomatic Pregnancies of Unknown Location

NCT02581761Unknown

Sponsor
Sheba Medical Center
Start
Nov 2015
Primary completion
Nov 2017
Modality
Small Molecules
01

Overview

Randomised, double-blind trial in Pregnancy of unknown location (PUL) comparing Cytotec treatment group with Placebo treatment group (2 arms). Primary endpoint: Uneventful decline of serum beta-HCG to an undetectable level (<2 IU/l) at 2 weeks. Status: unknown.

02

Drugs

misoprostol
03

Conditions

Pregnancy of unknown location (PUL)

Beyond the preview

Go deeper on NCT02581761.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02581761.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call